NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 89 filers reported holding NOVOCURE LTD in Q2 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $125,000 | -53.5% | 2,100 | -34.2% | 0.04% | -34.0% |
| Q4 2019 | $269,000 | +2.7% | 3,190 | -8.9% | 0.05% | -22.1% |
| Q3 2019 | $262,000 | +65.8% | 3,500 | +40.0% | 0.07% | +47.8% |
| Q2 2019 | $158,000 | -69.4% | 2,500 | -77.2% | 0.05% | -33.3% |
| Q1 2019 | $516,000 | +774.6% | 10,946 | +508.1% | 0.07% | +263.2% |
| Q4 2018 | $59,000 | -69.9% | 1,800 | -71.4% | 0.02% | -57.8% |
| Q2 2018 | $196,000 | +444.4% | 6,300 | +270.6% | 0.04% | +400.0% |
| Q1 2018 | $36,000 | +260.0% | 1,700 | +183.3% | 0.01% | +800.0% |
| Q2 2017 | $10,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |